Infectious Disease and Microbiology - South American Arenavirus Group

Basics

The South American arenavirus group consists of several closely related viruses responsible for severe viral hemorrhagic fever syndromes in South America. These viruses belong to the Tacaribe complex of arenaviruses and are related to the viruses responsible for Lassa fever and lymphocytic choriomeningitis.

Important viruses include:

• Junín virus — Argentine hemorrhagic fever

• Machupo virus — Bolivian hemorrhagic fever

• Guanarito virus — Venezuelan hemorrhagic fever

• Sabiá virus — Brazilian hemorrhagic fever

⸻

Microbiologic Characteristics

These pathogens are members of the arenavirus group and belong to the South American or Tacaribe complex.

Arenaviruses are enveloped RNA viruses maintained primarily in rodent reservoirs. Human infection usually occurs after exposure to infected rodents or material contaminated by their secretions or excreta.

They are related to:

• Lassa virus

• Lymphocytic choriomeningitis virus

⸻

Incubation Period

The usual incubation period is approximately:

7–16 days

Symptoms subsequently develop as an acute systemic febrile illness.

⸻

Epidemiology

South American arenavirus infections occur primarily in specific endemic regions of South America, where sporadic cases and occasional outbreaks have been reported.

Each virus is geographically associated with the hemorrhagic fever syndrome reflected in its name:

• Junín virus → Argentina

• Machupo virus → Bolivia

• Guanarito virus → Venezuela

• Sabiá virus → Brazil

Rodents serve as the principal natural reservoirs.

⸻

Transmission

The major route of human infection is exposure to infected rodent excreta or secretions.

Transmission commonly occurs through inhalation of small aerosolized particles contaminated with:

• Rodent urine

• Feces

• Saliva

Direct person-to-person transmission can occur with some arenaviruses but is considerably less common than rodent-associated transmission.

⸻

Clinical Presentation

South American arenavirus infections typically begin as an acute systemic febrile illness.

Common early manifestations include:

• Fever

• Severe headache

• Retro-orbital pain

• Profuse sweating

• Conjunctival injection

• Myalgias

• Malaise

• Marked weakness and prostration

The early illness may initially resemble several other systemic viral infections.

⸻

Severe Disease

Progressive infection can produce a potentially fatal hemorrhagic fever syndrome.

Severe manifestations may include:

• Hemorrhage

• Central nervous system dysfunction

• Bradycardia

• Hypotension

• Circulatory instability

Neurologic manifestations may become particularly prominent in severe disease.

⸻

Hemorrhagic Manifestations

Bleeding abnormalities may develop as the illness progresses.

Possible manifestations include:

• Petechiae

• Ecchymoses

• Mucosal bleeding

• Gastrointestinal bleeding

• Other manifestations of systemic hemorrhage

Hemorrhagic manifestations indicate severe systemic disease and require intensive supportive management.

⸻

Central Nervous System Involvement

Severe South American arenavirus infections can involve the CNS.

Patients may develop:

• Altered mental status

• Tremor

• Neurologic dysfunction

• Seizures or other severe neurologic manifestations

The combination of hemorrhage, neurologic abnormalities, and cardiovascular instability suggests advanced disease.

⸻

Diagnosis

Because these infections are uncommon and potentially dangerous, diagnosis requires specialized laboratory testing and appropriate biosafety precautions.

Viral Detection

Diagnosis may be established through:

• Detection of viral nucleic acid by molecular methods such as RT-PCR

• Detection of viral antigen in blood or affected tissues

• Virus isolation in appropriately equipped specialized laboratories

Routine clinical laboratories generally should not attempt viral culture when a highly pathogenic arenavirus is suspected.

⸻

Serology

Serologic testing can demonstrate antibodies directed against the causative arenavirus.

Testing may include detection of:

• Virus-specific IgM

• Rising virus-specific antibody titers

Serology can therefore support the diagnosis when interpreted in conjunction with the clinical presentation and epidemiologic exposure.

⸻

Differential Diagnosis

South American arenavirus hemorrhagic fever should be distinguished from other causes of acute febrile or hemorrhagic illness, including:

• Dengue

• Yellow fever

• Lassa fever

• Other viral hemorrhagic fevers

• Severe malaria

• Leptospirosis

• Typhoid fever

• Meningococcemia

• Severe bacterial sepsis

The combination of appropriate South American exposure + rodent contact + acute fever + hemorrhagic or neurologic manifestations should raise suspicion for an arenavirus infection.

⸻

Treatment

Supportive Care

Management primarily requires careful supportive treatment.

Depending on severity, patients may require:

• Intravenous fluid and electrolyte management

• Hemodynamic support

• Management of bleeding

• Respiratory support

• Treatment of shock

• Intensive monitoring for neurologic and cardiovascular complications

⸻

Ribavirin

Historically, ribavirin has been used for South American arenavirus hemorrhagic fevers, although the quality and extent of clinical evidence vary substantially by virus.

Because these are rare, severe infections, antiviral treatment should be directed with expert infectious-disease and public-health consultation rather than assuming that the same regimen is established for all four viruses.

⸻

Argentine Hemorrhagic Fever

For Junín virus infection, early administration of immune plasma containing neutralizing antibodies has historically demonstrated substantial benefit.

Treatment is most effective when administered early in the course of illness, particularly within approximately the first 8 days after symptom onset.

This is a distinctive therapeutic feature of Argentine hemorrhagic fever.

⸻

Prevention

Rodent Control

Prevention centers on minimizing human exposure to infected rodents and their excreta.

Important measures include:

• Controlling rodent populations

• Preventing rodents from entering homes and workplaces

• Protecting stored food from rodent contamination

• Avoiding direct contact with rodent urine, feces, and saliva

• Safely cleaning rodent-contaminated environments

Because aerosolization can transmit infection, contaminated rodent material should not be swept or handled in a way that generates airborne particles.

⸻

Infection-Control Precautions

Patients with suspected South American arenavirus hemorrhagic fever require prompt isolation and rigorous infection-control precautions, particularly when hemorrhage or exposure to body fluids is possible.

Public-health and infectious-disease authorities should be involved promptly when a case is suspected.

⸻

Prognosis

These infections can be severe and potentially fatal.

Historically reported case-fatality rates for South American arenavirus hemorrhagic fevers have ranged approximately from:

10–30%

Mortality varies according to the specific virus, severity of disease, availability of supportive care, and access to effective early therapy.

⸻

High-Yield Clinical Pattern

South America + rodent exposure + acute fever + headache + retro-orbital pain + hemorrhage/CNS abnormalities

→ Think South American arenavirus hemorrhagic fever

Argentina

→ Junín virus

Bolivia

→ Machupo virus

Venezuela

→ Guanarito virus

Brazil

→ Sabiá virus

⸻

Exam Essentials

Virus group:

→ Arenaviruses

Complex:

→ Tacaribe complex

Major reservoir:

→ Rodents

Main transmission:

→ Inhalation or exposure to material contaminated by rodent excreta or secretions

Incubation period:

→ 7–16 days

Typical early illness:

→ Fever + headache + retro-orbital pain + myalgias + malaise

Severe manifestations:

→ Hemorrhage + CNS dysfunction + hypotension

Argentine hemorrhagic fever:

→ Junín virus

Bolivian hemorrhagic fever:

→ Machupo virus

Venezuelan hemorrhagic fever:

→ Guanarito virus

Brazilian hemorrhagic fever:

→ Sabiá virus

Important historical treatment for Junín virus:

→ Early immune plasma

Major preventive strategy:

→ Rodent control and avoidance of contaminated rodent excreta

Key clinical pearl: The combination of a compatible South American exposure, rodent contact, acute febrile illness, and subsequent hemorrhagic or neurologic manifestations should immediately raise concern for a South American arenavirus hemorrhagic fever.